Company News

Stay up to date on the exciting events that happen with Tower MSA and our industry.

Zohydro – Promised Relief or One More Opioid in the Spiral of Addiction?

Posted on March 5, 2014 by Rita Wilson

When Zogenix announced on October 25, 2013 that the U.S. Food and Drug Administration (FDA) had approved ZohydroTM ER (hydrocodone bitartrate) extended-release capsules,  an extended-release oral formulation of hydrocodone without acetaminophen, the announcement came with the promise of continuous relief in the management…

Read more

For Media Inquires, Contact:

Helen King Patterson

    Subscribe to our blog & news

    Search our blog:

    Contact Us for a FREE Consultation